The study uncovered the usual gastrointestinal issues linked to GLP-1 drugs, like abdominal pain, nausea and vomiting, as well as less well-known conditions, including stomach paralysis and diverticulitis, where bulging pouches of the large intestine become inflamed
About 24% of study participants reported constipation while taking Wegovy, which is FDA-approved specifically for weight loss
Effective Weight Management: In individuals with obesity or overweight, consistent semaglutide levels contribute to weight loss by reducing appetite, increasing feelings of fullness (satiety), and decreasing caloric intake
Your healthcare provider will assess your individual circumstances, including the reason for gallbladder removal and current digestive function, to determine whether weight loss injections represent a safe and appropriate treatment option for you
It's important to note that normal imaging does not exclude endometriosis